Stephen A. Berenson
Presently, Stephen A. Berenson occupies the position of Chairman of Seres Therapeutics, Inc., Chairman for Cellarity Inc. and Managing Partner at Flagship Pioneering. He is also on the board of CiBO Technologies, Inc., Moderna, Inc., The Mahaiwe Performing Arts Center and Repertoire Immune Medicines, Inc.
Mr. Berenson received an undergraduate degree from Massachusetts Institute of Technology.
Transactions
Date
Transaction
Value
| 04/28/2023 | 670 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 04/28/2022 | 703 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 08/19/2021 | 2,700 | Gift at $0 per share. | 0 |
| 12/11/2018 | 22,798 | Derivative/Non-derivative trans. at $0 per share. | 0 |
